Stuart O. Schweitzer
Affiliations: | University of California, Los Angeles, Los Angeles, CA |
Area:
Public Health, Health Care Management, Public Administration, Pharmacy, Marketing Business AdministrationGoogle:
"Stuart Schweitzer"Cross-listing: PHTree
Children
Sign in to add traineeJeffrey A. Shafiroff | grad student | 2001 | UCLA |
Judith Connell | grad student | 2002 | UCLA |
Lori S. Pelliccioni | grad student | 2002 | UCLA |
Stephanie I. Teleki | grad student | 2002 | UCLA |
Lyndon T. Castro | grad student | 2004 | UCLA |
Amanda S. Gilmore | grad student | 2007 | UCLA |
Jinnie Rhee | grad student | 2007 | UCLA |
Chih-Wen Shi | grad student | 2007 | UCLA |
George J. Joseph | grad student | 2010 | UCLA |
Julie A. Elginer | grad student | 2011 | UCLA |
Sunny Gill | grad student | 2011 | UCLA |
Weijun Zhang | grad student | 2011 | UCLA |
Daniel B. Seargeant | grad student | 2012 | UCLA |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Fujimoto J, Tien DM, Snyder S, et al. (2019) The effect of patent expiration on sales of branded competitor drugs in a therapeutic class Journal of Generic Medicines: the Business Journal For the Generic Medicines Sector. 15: 177-184 |
Comanor WS, Schweitzer SO, Riddle JM, et al. (2018) Value Based Pricing of Pharmaceuticals in the US and UK: Does Centralized Cost Effectiveness Analysis Matter? Review of Industrial Organization. 52: 589-602 |
Liang D, Zhang D, Huang J, et al. (2016) Does Rapid and Sustained Economic Growth Lead to Convergence in Health Resources: The Case of China From 1980 to 2010. Inquiry : a Journal of Medical Care Organization, Provision and Financing. 53 |
Schweitzer SO, Comanor WS. (2011) Prices of pharmaceuticals in poor countries are much lower than in wealthy countries. Health Affairs (Project Hope). 30: 1553-61 |
Di Tommaso MR, Schweitzer SO. (2010) Production and transfer of academic knowledge: Policy targets and implications for the health industry International Journal of Healthcare Technology and Management. 11: 227-240 |
Schweitzer SO. (2008) Trying times at the FDA--the challenge of ensuring the safety of imported pharmaceuticals. The New England Journal of Medicine. 358: 1773-7 |
Chen Y, Schweitzer SO. (2008) Issues in drug pricing, reimbursement, and access in China with references to other Asia-Pacific region. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 11: S124-9 |
Schweitzer SO. (2007) Book Review: Restoring Fiscal Sanity 2007: The Health Spending Challenge Inquiry: the Journal of Health Care Organization, Provision, and Financing. 44: 495-496 |
Schweitzer SO. (2007) Introduction: How will health systems adopt new genetics technology? International Journal of Healthcare Technology and Management. 8: 417-425 |
Comanor WS, Schweitzer SO. (2007) Determinants of drug prices and expenditures Managerial and Decision Economics. 28: 357-370 |